Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.22M Buy
+8,486
New +$2.18M 0.47% 48
2026
Q1
$3.51M Buy
16,154
+766
+5% +$170K 0.26% 78
2025
Q4
$3.52M Buy
15,388
+2,739
+22% +$624K 0.26% 71
2025
Q3
$2.93M Sell
12,649
-9,927
-44% -$2.02M 0.38% 52
2025
Q2
$4.19M Buy
22,576
+2,313
+11% +$430K 0.33% 58
2025
Q1
$4.25M Sell
20,263
-896
-4% -$174K 0.61% 32
2024
Q4
$3.76M Sell
21,159
-1,069
-5% -$197K 0.34% 52
2024
Q3
$4.39M Buy
22,228
+1,445
+7% +$270K 0.4% 44
2024
Q2
$3.56M Buy
20,783
+10,171
+96% +$1.68M 0.36% 49
2024
Q1
$1.93M Sell
10,612
-7,728
-42% -$1.33M 0.2% 88
2023
Q4
$2.92M Buy
+18,340
New +$2.67M 0.3% 57

Other funds holding ABBV

Leo Wealth's ABBV Position: Q3 2026 in Review

Leo Wealth opened a new position in AbbVie (ABBV) in Q3 2026: 8,486 shares worth $2.22M. The stake represents 0.47% of the portfolio and ranks #48 among its holdings. This is a return to the name: Leo Wealth previously reported a position in ABBV as recently as Q1 2026.

Leo Wealth first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.39M in Q3 2024. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Leo Wealth held 8,486 shares of AbbVie worth $2.22M as of Q3 2026.
  • AbbVie was a new Leo Wealth position in Q3 2026.
  • AbbVie made up 0.47% of Leo Wealth's portfolio in Q3 2026, its #48 holding.
  • Leo Wealth first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • Leo Wealth's AbbVie position peaked at $4.39M in Q3 2024.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Leo Wealth's 13F filing for Q3 2026, filed 26 Oct 2026.